CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)	Ordinary Shares [Member] Class A Ordinary Shares [Member]	Ordinary Shares [Member] Class B Ordinary Shares [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total	Class A Ordinary Shares [Member]
Beginning balance at Dec. 31, 2020	$ 0	$ 719	$ 24,281	$ (12,845)	$ 12,155
Beginning balance (in shares) at Dec. 31, 2020	0	7,187,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of Units in Initial Public Offering	$ 2,500		249,997,500	0	250,000,000
Sale of Units in Initial Public Offering (in shares)	25,000,000
Private placement warrants	$ 0	$ 0	7,000,000	0	7,000,000
Underwriters' discount	0	0	(5,000,000)	0	(5,000,000)
Deferred underwriting discount	0	0	(8,750,000)	0	(8,750,000)
Initial value of public warrant liabilities	0	0	(11,061,035)	0	(11,061,035)
Initial value of private warrant liabilities	0	0	(6,203,050)	0	(6,203,050)
Allocation of offering cost to warrant liability	0	0	634,367	0	634,367
Other offering costs	0	0	(587,871)	0	(587,871)
Initial maximum number of redeemable shares	$ (2,204)	$ 0	(220,405,286)	0	(220,407,490)
Initial maximum number of redeemable shares (in shares)	(22,040,749)	0
Change in maximum number of redeemable shares	$ (3)	$ 0	(258,737)	0	(258,740)
Change in maximum number of redeemable shares (in shares)	(25,874)	0
Net income	$ 0	$ 0	0	(378,329)	(378,329)
Ending balance at Mar. 31, 2021	$ 293	$ 719	5,390,169	(391,174)	5,000,007
Ending balance (in shares) at Mar. 31, 2021	2,933,377	7,187,500
Beginning balance at Dec. 31, 2020	$ 0	$ 719	24,281	(12,845)	12,155
Beginning balance (in shares) at Dec. 31, 2020	0	7,187,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of Units in Initial Public Offering (in shares)						6,875,000
Net income					4,251,586
Ending balance at Jun. 30, 2021	$ 271	$ 688	760,301	4,238,741	5,000,001
Ending balance (in shares) at Jun. 30, 2021	2,712,064	6,875,000
Beginning balance at Mar. 31, 2021	$ 293	$ 719	5,390,169	(391,174)	5,000,007
Beginning balance (in shares) at Mar. 31, 2021	2,933,377	7,187,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of Option Units to underwriters	$ 250	$ 0	24,999,750	0	25,000,000
Sale of Option Units to underwriters (in shares)	2,500,000
Forfeiture of Founder Shares pursuant to Over-allotment	$ 0	$ (31)	31	0	0
Forfeiture of Founder Shares pursuant to Over-allotment (in shares)		(312,500)
Deferred underwriting discount	0	$ 0	(875,000)	0	(875,000)
Initial value of Over-allotment Public warrant liabilities	0	0	(1,100,488)	0	(1,100,488)
Initial value of Over-allotment Private warrant liabilities	0	0	(441,302)	0	(441,302)
Change in maximum number of redeemable shares	$ (272)	$ 0	(27,212,859)	0	(27,213,131)
Change in maximum number of redeemable shares (in shares)	(2,721,313)	0
Net income	$ 0	$ 0	0	4,629,915	4,629,915
Ending balance at Jun. 30, 2021	$ 271	$ 688	$ 760,301	$ 4,238,741	$ 5,000,001
Ending balance (in shares) at Jun. 30, 2021	2,712,064	6,875,000